|
[1]
|
A buprenorphine depot formulation provides effective sustained post-surgical analgesia for 72 h in mouse femoral fracture models
Scientific Reports,
2023
DOI:10.1038/s41598-023-30641-9
|
|
|
|
|
[2]
|
Serum Concentrations of a Long-acting Cat Formulation of Transdermal Buprenorphine in C57BL/6 Mice
Journal of the American Association for Laboratory Animal Science,
2023
DOI:10.30802/AALAS-JAALAS-22-000101
|
|
|
|
|
[3]
|
A Review of Long-acting Parenteral Analgesics for Mice and Rats
Journal of the American Association for Laboratory Animal Science,
2022
DOI:10.30802/AALAS-JAALAS-22-000061
|
|
|
|
|
[4]
|
Lipid bound extended release buprenorphine (high and low doses) and sustained release buprenorphine effectively attenuate post‐operative hypersensitivity in an incisional pain model in mice (
Mus musculus
)
Animal Models and Experimental Medicine,
2021
DOI:10.1002/ame2.12157
|
|
|
|
|
[5]
|
Design and in vivo evaluation of a microparticulate depot formulation of buprenorphine for veterinary use
Scientific Reports,
2020
DOI:10.1038/s41598-020-74230-6
|
|
|
|
|
[6]
|
Design and in vivo evaluation of a microparticulate depot formulation of buprenorphine for veterinary use
Scientific Reports,
2020
DOI:10.1038/s41598-020-74230-6
|
|
|
|
|
[7]
|
Evaluation of buprenorphine hydrochloride Pluronic® gel formulation in male C57BL/6NCrl mice
Lab Animal,
2016
DOI:10.1038/laban.1106
|
|
|
|
|
[8]
|
Current options for providing sustained analgesia to laboratory animals
Lab Animal,
2014
DOI:10.1038/laban.590
|
|
|
|
|
[9]
|
Safety and efficacy of buprenorphine for analgesia in laboratory mice and rats
Lab Animal,
2012
DOI:10.1038/laban.152
|
|
|
|